JOHN J LIPUMA, MD
Medical Practice in Ann Arbor, MI

License number
Michigan 4301044245
Category
Medical Practice
Type
Pediatrics
License number
Michigan 4301044245
Category
Medical Practice
Type
Pediatric Infectious Diseases
Address
Address
1500 C.s. Mott CHILDREN'S HOSPITAL FLOOR 6TH, Ann Arbor, MI 48109
Phone
(734) 936-4185
(734) 936-2047

Personal information

See more information about JOHN J LIPUMA at radaris.com
Name
Address
Phone
John Lipuma
1618 Shadford Rd, Ann Arbor, MI 48104
John Lipuma, age 70
1618 Shadford Rd APT 68, Ann Arbor, MI 48104
John Lipuma
17372 Pacific St, Atlantic Mine, MI 49905
(906) 483-0292
John L Lipuma, age 76
101 Alston Ave, Baraga, MI 49908
(906) 353-7930
John Lipuma
3E Rr 1, Atlantic Mine, MI 49905

Professional information

John J Lipuma Photo 1

John J Lipuma, Ann Arbor MI

Specialties:
Pediatrician
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
3621 S State St, Ann Arbor, MI 48108
Education:
Saint Louis University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Infectious Diseases (Pediatrics)


John J Lipuma Photo 2

Dr. John J Lipuma, Ann Arbor MI - MD (Doctor of Medicine)

Specialties:
Pediatric Infectious Disease Medicine
Address:
University MI Pedtrc Infcts Dis
1500 E Medical Center Dr SUITE 5718, Ann Arbor 48109
(734) 763-2440 (Phone)
Certifications:
Pediatric Infectious Disease Medicine, 2002, Pediatrics, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University MI Pedtrc Infcts Dis
1500 E Medical Center Dr SUITE 5718, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Saint Louis University / School of Medicine
Graduated: 1980
Cs Mott Chldns Hosp-U Mich
University Of Michigan Hospitals


John Lipuma Photo 3

Nanoemulsion Therapeutic Compositions And Methods Of Using The Same

US Patent:
2008031, Dec 25, 2008
Filed:
May 2, 2008
Appl. No.:
12/114573
Inventors:
James R. Baker - Ann Arbor MI, US
Sivaprakash Rathinavelu - Naperville IL, US
Paul E. Makidon - Webberville MI, US
John J. LiPuma - Ann Arbor MI, US
Shraddha Nigavekar - Columbia TN, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A01N 25/04, A61K 9/12, A01N 25/06, A61K 9/107, A61P 31/00, A01P 1/00
US Classification:
424405, 424 45, 424400
Abstract:
The present invention relates to methods and compositions for treating pulmonary infection. In particular, the present invention provides nanoemulsion compositions and methods of using the same to treat bacteria associated with biofilms (e.g., found in pulmonary infections). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.


John Lipuma Photo 4

Nanoemulsion Therapeutic Compositions And Methods Of Using The Same

US Patent:
2010020, Aug 12, 2010
Filed:
Sep 25, 2009
Appl. No.:
12/567571
Inventors:
Mark R. Hemmila - Superior Township MI, US
Stewart C. Wang - Ann Arbor MI, US
Tarek Hamouda - Milan MI, US
John J. LiPuma - Ann Arbor MI, US
Jessica A. Knowlton - Ypsilanti MI, US
Paul E. Makidon - Webberville MI, US
Luz P. Blanco - Ann Arbor MI, US
Anna U. Bielinska - Ypsilanti MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 9/107, A61K 39/02, A61P 31/04
US Classification:
424484, 4242341, 4241901
Abstract:
The present invention relates to therapeutic nanoemulsion compositions and to methods of utilizing the same. In particular, nanoemulsion compositions are described herein that find use in the treatment and/or prevention of infection (e.g., respiratory infection (e.g., associated with cystic fibrosis)), in burn wound management, and in immunogenic compositions (e.g., comprising a antigen) that generate an effective immune response (e.g., against a bacterial species of the genus ) in a subject administered the immunogenic composition. Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine), industrial, and research applications.